A B S T R A C T Although it is generally accepted that DNA:anti-DNA immune complexes play a significant role in the pathogenesis of tissue injury in systemic lupus erythematosus, their presence in the circulation is still a matter of controversy. In this study, we detected DNA:anti-DNA complexes by identification of both the antigen and(or) the antibody, the necessary requisites for immune complex definition, in 14 of 24 plasmas (7 of 11 patients). These antibodies were specific for native DNA and could be adsorbed by anti-immunoglobulin (Ig)G antisera. The DNA recovered was, at least in part, of low molecular weight. The presence of DNA: anti-DNA complexes was not related to high molecular weight IgG, cryoprecipitins, positive polyethylene glycol precipitation, or low plasma C3 levels. It was related significantly to low plasma C4 levels and to the presence of diffuse proliferative nephritis. The lack of correlation with other methods of detection of immune complexes and with the presence of heavy IgG (above 13 S) is in favor of the existence of other antigen-antibody systems (or aggregated immunoglobulins) in systemic lupus erythematosus plasmas. From the results, it appears that methods directed towards the demonstration of specific immune complexes are more informative than those detecting heavy or altered immunoglobulins.
INTRODUCTION
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complex (IC) deposition plays an important pathogenic role (1, 2) . Many techniques have been developed recently to detect circulating IC, and evidence for their existence in SLE sera has been obtained with most of them (3) . However, these methods are not specific for IC (4, 5) and do not permit their characterization.
Although there is evidence that some of the circulating IC are composed of DNA and antibody to DNA (6) (7) (8) (9) , the subject is still controversial. Recently published articles have disputed the presence of these IC in the circulation in any significant amount (10) (11) (12) . Moreover, some studies suggest that DNA:anti-DNA IC may be formed inl situ rather than deposited (13, 14) . According to the definition of "immune complexes," the identification of the antigen and the antibody is a desirable goal when attempting to detect the presence of IC. In the last analysis, it does not appear that this condition has been adequately met by most investigators.
In this article, we present the results obtained after ultracentrifugation of SLE plasmas in sucrose density gradients at physiologic and acid pHs. We have shown that this method was adequate for the detection and dissociation of IC formed in vitro, including DNA:anti-DNA IC, and allowed the recovery of the components of these IC (15) . We demonstrate here the presence of DNA:anti-DNA IC, i.e., the identification of anti-DNA antibody and of DNA after dissociation of high molecular weight material, in 14 of 24 SLE plasmas (7 of 11 patients). These results are compared with the presence of high molecular weight immunoglobulin (Ig)G, with other tests used for the detection of circulating IC, and with some clinical features.
METHODS
Patientts anid plasmas. 24 plasmas from 11 patients fulfilling the American Rheumatism Association criteria for SLE (16) were studied. Four samples were obtained from one patient, three from each of five patients, and five from five patients. Heparinized blood was centrifuged at room temperature.
Plasmas were kept at -20°C in frozen aliquots and thawed only once. They were used in preference to sera because the release of DNA during clotting may have resulted in the formation of DNA:anti-DNA IC (17) .
Analytical ultracentrifugation. These plasmas were analyzed by ultracentrifugation at 170,000 g for 14 h in sucrose gradients as described previously (15) . Briefly, 100 ,ul of plasma, diluted twofold in 0.14 M saline buffered with 0.01 M Tris, pH 7.4 (Tris-buffered saline [TBS]), was analyzed in 10-37% (wt/vol) sucrose gradients dissolved either in TBS or in 0.12 M glycine-HCl buffer, pH 2.8. All parameters measured in gradients were plotted on millimetric paper against the gradient volume expressed in percentage oftotal. The total surface and the areas of zones 0-5 S, 5-9 S, 9-13 S, 13-17 S, and above 21 S, delimited by comparison with the position of markers, were measured by planimetry and expressed in centimeters squared. The 7-S peak was found at 70-74% of the gradient (top: 100%), and the 19-S peak was at 36-40%. In some instances, the heavy fractions of SLE plasmas (from 25 to 30 S), obtained from aliquots of an individual plasma fractionated on six -sucrose gradients at pH 7.4, were pooled, dialyzed against TBS and concentrated about five times on a PM 30 Amicon membrane (Amicon Corp., Scientific Sys. Div., Lexington, Mass.). They were then ultracentrifuged a second time at pH 7.4 and 2.8. We have described elsewhere the recentrifugation technique (15) . In these studies, we have measured the total recovery of several proteins separated on neutral or acid gradients. 90-95% of isolated IgM, IgA, IgG, or bovine serum albumin (BSA), were recovered. When BSA: anti-BSA IC were centrifuged, recovery of the radiolabeled BSA from the whole gradient was at both pHs above 95% for IC at 100:1 and 20:1 antigen excess. On acid gradients, we recovered 91.4 and 85.6% of the 125I-BSA applied to the gradient in the zone 0-9 S for IC at 100:1 and 20:1 antigen excess, respectively (15) Other technical parameters. The solid phase radioimmunoassay for IgG, the preparation of immunoadsorbants, and the 125I-labeling of proteins have been used as described already (15) . From previous experiments, we determined that the IgG distribution of fresh plasmas or of plasmas stored at -20°C for <1 mo could be reliably studied at both pHs. Those stored at -20°C for 1-6 mo were suitable for analysis at pH 7.4 only. Decomplementation by heating at 56°C for 30 min also altered this IgG distribution.
Precipitation with 3.5% polyethylene glycol (PEG) was performed as described by Creighton et al. (19) , and OD readings at 280 nm exceeding 0.120 were considered abnormal. Cryoprecipitation was read after 4 d at 4°C. The amount of precipitate that could be dissolved at 37°C was graded from 1+ to 3+. C3 and C4 levels were determined by radial immunodiffusion in agar gel (Partigen, Behring, Marburg/Lahn, West Germany). Values below 60 mg/100 ml for C3 and 16 mg/100 ml for C4 were considered abnormal.
RESULTS

DBC of normal plasmas
Altogether, 298 individual determinations of DBC were performed on fractions obtained from 10 normal plasmas, after ultracentrifugation at pH 7.4 and 2.8, out of which one reached 12.5%, two were between 10 and 12.5%, and 10 were between 5 and 10%. All others were below 5%. These results were plotted on millimetric paper, and the DBC in zones and total gradients were expressed in square centimeters (Table 1) . For the total gradient, this upper limit was 14.33 cm2 at pH 7.4 and 18.87 cm2 at pH 2.8. The mean +2 SD of DBC in individual zones or in the total gradients was taken as the upper normal limit, above which we considered the activity to be significant. DBC of SLE plasmas (24 plasmas from 11 patients)
Reproducibility. To assess the reproducibility of gradient analysis, the distribution of DBC of an IgG fraction of one SLE plasma was fractionated on three separate occasions at pH 7.4 and 2.8. There was no difference in distribution between pH 7.4 and 2.8 or between the different experiments ( Table II) . Plasmas that exhibited increase in DBC in the 7-S fraction after acid dissociation (see below) were also repeatedly frac- (Table III) ; a 5-to 9-S zone of peak activity, defined as a zone containing >35% of the total DBC ofthe gradient, was identified in 13 ofthese 19 plasmas; and a peak above 21 S was found in four. There was no zone of peak activity in two plasmas with a low total DBC of 19 and 32.3 cm2. Altogether, significant activity was found above 13 S in 17 plasmas.
Fractionation at pH 2.8. A total DBC, above the upper limit ofnormal (18.87 cm2), was found in 23 of the 24 plasmas (Table III) . A zone of peak activity between 5 and 9 S was identified in 19 plasmas. Four of the five plasmas which were within normal range at pH 7.4 showed significant antibody activity after fractionation at pH 2.8, their total DBC increasing from 14.3 to 28.3, 14 to 24.9, 13.4 to 29.2, and 8.5 to 28.9 cm2, respectively. Altogether, 14 plasmas retained significant DBC above 13 S. Table IV where only the significant DBC changes in the 5-to 9-S zone, above 21 S, and in the whole gradient, are presented. The DBC in the total gradient was increased in 6 of 24 plasmas by a mean of 45%, and in the 5-to 9-S zone in 11 plasmas by a mean of 108% (Table V) . 5 of these last 11 were included in the six exhibiting an increase in total activity. The DBC in the zone above 21 S was always less at pH 2.8 than at pH 7.4, this decrease reached significance in six plasmas. There was no significant difference in the distribution and titer of DBC in 8 of the 24 plasmas (not shown in Table  V ). In four of these, no significant DBC has been found above 13 S at pH 7.4; in the others, there had been significant, but moderate, DBC above 13 S (<18% of the total DBC). In six patients serial samples were analyzed. In two patients, there was no DNA:anti-DNA IC; in two patients, they were present in all three of the serial samples; in two other patients, in one or two of the three samples. The data are insufficient to establish clinical correlates in these individual cases.
The 7-S gradient fractions of seven plasmas showing increases in DBC after fractionation at pH 2.8 were further analyzed (Table VI) . The DBC of the fractions recovered at pH 2.8 and then brought to pH 7.4 was precipitated by 50% saturated ammonium sulfate (SAS) Table I ). In parenthesis are indicated the values above which DBC are significant as defined in Table III No significant change in titer or distribution in eight plasmas. * Changes were considered significant when differences in the whole gradient or in individual zones were in excess ofthe mean +2 SD of differences found in normal plasmas.
t Number of plasmas. 
Refractionation of previously isolated heavy components
The 25-to 30-S, pH 7.4 fractions ofplasmas from three patients with DNA:anti-DNA complexes, as defined above, were ultracentrifuged a second time (Table VII and Fig. 2 ). There was no significant DBC at pH 7.4 except above 21 S in plasma 2. At pH 2.8, significant binding activity, localized mainly to the 5-to 9-S zone, appeared in the three experiments. This activity was found in the 50% SAS precipitates and bound [3H]SV-40 DNA as well as E. coli [14C]DNA. In plasmas 2 and 3, the binding in the 5-to 9-S zone was sufficient to demonstrate its adsorption by an anti-y-chain antiserum. Only in experiment 2 was there sufficient IgG to be measured by our radioimmunoassay. About 120 ng/ml were found above 21 S at pH 7.4. This peak disappeared at pH 2.8, and 150 ng/ml were then detected in the zone 5-to 9-S. In the two other experiments, DBC was present at pH 2.8 in the absence of detectable IgG by our radioimmunoassay.
DNA was measured after 50% ammonium sulfate precipitation in the globulin-free dialyzates of these fractions by inhibition of the Farr assay as described in Methods. After fractionation at pH 7.4, DNA was detected in the heaviest fractions in the three experiments and, in small amounts, in the 4-to 6-S zone in one Table III are underlined. Significant differences as defined in Table IV are underlined twice.
( (Fig. 4) . However, some increase in IgG above 13 S was found in six plasmas in the absence of cryoglobulinemia or positive PEG precipitation. These tests were also positive, one each in two different plasmas in the absence of heavy IgG. There was no relationship between the presence of heavy IgG and the levels of plasma C3 or C4. more heavy IgG than the negative ones; no differences were found between the IC-positive and the IC-negative sera in their cryoglobulin and PEG-precipitable protein content. Conversely, C4 levels were significantly lower in the presence of DNA:anti-DNA IC: values below 16 mg/100 ml were found in six of nine plasmas containing IC vs. one of seven without IC. There was no difference in C3 concentration between IC-positive and IC-negative plasmas.
DNA:anti-DNA IC were present at some time in 7 of the 11 patients studied. Five ofthese had a proliferative glomerulonephritis proven by biopsy; one had an abnormal urinary sediment but a biopsy was not performed; the other had a severe Coombs' positive hemolytic anemia and extensive skin involvement. Of the four patients without circulating DNA:anti-DNA IC, one had a proliferative nephritis on a first renal biopsy but a repeat biopsy performed 2 yr later, and 2 mo before the studies on his plasma, was normal on light microscopy. IgG, IgA, and IgM deposits were detected by immunofluorescence in the first biopsy, whereas IgA and IgM were present in the second one. No renal involvement was found in three, two of whom presented with predominantly articular symptoms and one with purpura, thrombocytopenia, and an acquired von Willebrand syndrome.
Relationship between DNA:anti-DNA and other parameters The amounts of heavy IgG (above 13 S) were not different in the specific IC-positive plasmas, as compared with the negative ones (Fig. 4 
DISCUSSION
Recovery ofanti-DNA antibodies and DNA after dissociation as evidence for DNA:anti-DNA IC. Significant increases in total DBC and, more frequently and importantly, in DBC titers of the 5-to 9-S zone were seen in 14 of the 24 SLE plasmas after dissociation at pH 2.8. There remained a significant DBC above 13 S in 14 of the 24 plasmas, which suggests that either DNA:anti-DNA IC were not completely dissociated or that storage caused irreversible aggregation ofanti-DNA antibodies or IC. We demonstrated that this DBC was directed against a native, circular, viral DNA, and was IgG-dependent, as shown by its precipitation in 50% SAS and its immunoadsorption to an anti-IgG gel. A decrease in total DBC and in the activity ofthe 5-to 9-S zone at pH 2.8 was found only once. This may be a result of the liberation from IC of DNA with a 7 S and the subsequent reformation of IC upon neutralization of the gradient fractions. This effect may have also impeded the recovery of anti-DNA antibody after fractionation at pH 2.8 in the 7-S zone in the other plasmas studied.
On second fractionation ofheavy components of SLE plasmas, significant 7-S DBC against E. coli DNA and native, circular, viral DNA was unmasked after the acid pH centrifugation. This activity was also precipitated in 50% SAS and adsorbed to an anti-IgG gel. In these 196 C. Bruneau and J. Benveniste (7) , in a study of cryoprecipitates from SLE patients, demonstrated that DNA antibodies were highly enriched in the precipitates relative to serum levels. In many of them, DNA was detected by a diphenylamine assay but not by hemagglutination inhibition, even after sucrose gradient ultracentrifugation at pH 3.5 (7) . DNA has also been found by the diphenylamine assay in the cryoglobulins of patients with Waldenstrom's macroglobulinemia and with essential mixed cryoglobulinemia (22) . Other workers could not find evidence for the presence of DNA:anti-DNA IC in the circulation in a mouse experimental model (23) and in man (12) by methods such as the measurement of Clq binding activity before and after DNase digestion or the measurement of human IgG after fixation of IgG: DNA complexes to methylated BSA coupled to gel. In the face of these discrepancies, our results strongly support the existence of DNA:anti-DNA IC in SLE plasmas. In effect we fulfilled the essential criteria for their presence by recovering anti-DNA antibody after acid dissociation in most SLE plasmas and DNA in some of these.
Acid dissociation has the further advantage of allowing the isolation of DNA for further characterization. (12, 21) . Further analysis of more SLE plasmas is needed to establish the value of these measurements in following disease course, but it already appears that these circulating IC are frequently present in SLE plasmas, and that by acid dissociation the antibody and the DNA involved may be isolated for further study.
This technique is already no more cumbersome than many others used for IC detection, and appears worthwhile in that it allows the isolation of specific IC and the recovery of antigen and antibody. It is restricted to pathological situations where the nature of the antigen is suspected, which already represents a large number of IC diseases. It is, however, conceivable that, when fully automatized, a panel of antigens could be tested for more precise identification of the pathological agents responsible for these diseases.
